Us Bancorp \De\ Trinity Biotech PLC Transaction History

Us Bancorp \De\

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.96 - $1.44 $62 - $93	-65 Reduced 6.27%	972 $1,000
Q3 2021 Nov 10, 2021	SELL	$1.82 - $2.94 $149 - $241	-82 Reduced 7.33%	1,037 $2,000
Q4 2020 Feb 04, 2021	SELL	$1.95 - $4.77 $191 - $467	-98 Reduced 8.05%	1,119 $4,000
Q2 2020 Aug 07, 2020	SELL	$0.88 - $2.55 $4 - $12	-5 Reduced 0.41%	1,217 $3,000
Q3 2019 Nov 08, 2019	SELL	$1.21 - $2.59 $1,070 - $2,292	-885 Reduced 42.0%	1,222 $1,000
Q2 2019 Aug 13, 2019	SELL	$1.57 - $3.02 $6,683 - $12,856	-4,257 Reduced 66.89%	2,107 $3,000
Q1 2019 May 08, 2019	SELL	$2.31 - $3.22 $9,159 - $12,767	-3,965 Reduced 38.39%	6,364 $18,000
Q3 2018 Nov 01, 2018	SELL	$3.76 - $5.08 $5,888 - $7,955	-1,566 Reduced 13.17%	10,329 $41,000
Q2 2018 Aug 08, 2018	SELL	$4.46 - $5.2 $40,144 - $46,805	-9,001 Reduced 43.08%	11,895 $59,000
Q1 2018 May 08, 2018	SELL	$5.08 - $6.06 $82,372 - $98,262	-16,215 Reduced 43.69%	20,896 $108,000
Q4 2017 Feb 02, 2018	SELL	$4.5 - $5.77 $145,624 - $186,722	-32,361 Reduced 46.58%	37,111 $189,000
Q3 2017 Nov 13, 2017	BUY	$5.16 - $5.67 $358,475 - $393,906	69,472	69,472 $390,000

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $29M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.